The article says insurers assess these requests through formulary status, drug tier, prior authorization rules, and the FDA-approved indication
Similar to an expiration date, a BUD is the date after which a compounded medication is no longer considered safe or effective to use, based on factors such as preparation method, ingredients, and storage conditions
Se centra especialmente en el impacto que estn teniendo los medicamentos que contienen dulaglutida y semaglutida (el famoso frmaco que escasea en las farmacias debido a sus efectos adelgazantes popularizados por los famosos), y en cmo estn revolucionando la visin de esta enfermedad, ya que los pacientes pueden prescindir tanto de la insulina como de otros frmacos hipoglucemiantes
Despite FDA crackdown, unapproved GLP-1s still threaten the industry Legitimate compounders are threatened by false advertising of counterfeit GLP-1s, legal experts warn